Page last updated: 2024-08-18

pyrroles and Dermatomyositis, Adult Type

pyrroles has been researched along with Dermatomyositis, Adult Type in 17 studies

Research

Studies (17)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (5.88)	29.6817
2010's	11 (64.71)	24.3611
2020's	5 (29.41)	2.80

Authors

Authors	Studies
Albayda, J; Castillo, R	1
Eason, C; Elston, D; Plante, J; Robinson, I; Santa Lucia, G	1
Allenbach, Y; Benveniste, O; Landon-Cardinal, O	1
Almeida de Jesus, A; Carrasco, R; Goldbach-Mansky, R; Hwang, S; Jung, L; Kim, H; Kuehn, HS; Rider, LG; Rosenzweig, S; Sabbagh, S	1
Jiménez-Gallo, D; Linares-Barrios, M; Navarro-Navarro, I; Rodríguez-Hernández, C; Rodríguez-Mateos, ME	1
Fujiwara, M; Ishikawa, Y; Kasuya, T; Kita, Y	1
Crespo Cruz, A; Del Boz, J; Romero Gómez, C	1
Arai, S; Arima, M; Kurasawa, K; Maezawa, R; Namiki, Y; Owada, T; Takamura, Y; Tanaka, A	1
Aggarwal, R; Charlton, D; Moghadam-Kia, S; Oddis, CV	1
Agarwal, P; Frye, BC; May, AM; Rizzi, M; Thiel, J; Venhoff, N; Voll, RE; Wendel, S	1
Chen, Z; Wang, X; Ye, S	1
Komai, E; Takemoto, M; Yokote, K	1
Femia, AN; Kurtzman, DJ; Lin, J; Merola, JF; Patel, M; Vleugels, RA; Wright, NA	1
Christopher-Stine, L; Paik, JJ	1
Hydzik, P; Szpak, D	1
Cannon, CS	1
Cerottini, JP; Noël, B; Panizzon, RG	1

Trials

1 trial(s) available for pyrroles and Dermatomyositis, Adult Type

Article	Year
Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease. The New England journal of medicine, 2019, 07-18, Volume: 381, Issue:3 Topics: Adult; Autoantibodies; Dermatomyositis; Drug Therapy, Combination; Female; Glucocorticoids; Historically Controlled Study; Humans; Interferon-Induced Helicase, IFIH1; Janus Kinase Inhibitors; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Piperidines; Pyrimidines; Pyrroles	2019

Article

Year

Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease.

The New England journal of medicine, 2019, 07-18, Volume: 381, Issue:3

Topics: Adult; Autoantibodies; Dermatomyositis; Drug Therapy, Combination; Female; Glucocorticoids; Historically Controlled Study; Humans; Interferon-Induced Helicase, IFIH1; Janus Kinase Inhibitors; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Piperidines; Pyrimidines; Pyrroles

2019

Other Studies

16 other study(ies) available for pyrroles and Dermatomyositis, Adult Type

Article	Year
Refractory alopecia universalis associated with dermatomyositis successfully treated with tofacitinib. Modern rheumatology case reports, 2022, 06-24, Volume: 6, Issue:2 Topics: Adult; Alopecia; Alopecia Areata; Dermatomyositis; Female; Humans; Interferons; Piperidines; Pyrimidines; Pyrroles	2022
A Retrospective Review of Tofacitinib in the Treatment of Refractory Dermatomyositis. Journal of drugs in dermatology : JDD, 2022, Oct-01, Volume: 21, Issue:10 Topics: Dermatomyositis; Humans; Immunologic Factors; Piperidines; Pyrimidines; Pyrroles; Retrospective Studies; Treatment Outcome	2022
Reply: Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib. Brain : a journal of neurology, 2019, 11-01, Volume: 142, Issue:11 Topics: Autoantibodies; Dermatomyositis; Humans; Piperidines; Pyrimidines; Pyrroles	2019
Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib. Brain : a journal of neurology, 2019, 11-01, Volume: 142, Issue:11 Topics: Autoantibodies; Dermatomyositis; Humans; Interferon Type I; Piperidines; Pyrimidines; Pyrroles	2019
Treatment of refractory anti-NXP2 and anti-TIF1γ dermatomyositis with tofacitinib. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2021, Volume: 19, Issue:3 Topics: Autoantibodies; Dermatomyositis; Humans; Piperidines; Pyrimidines; Pyrroles	2021
Tofacitinib for recurrence of antimelanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis after remission: A case report. Medicine, 2020, Sep-11, Volume: 99, Issue:37 Topics: Autoantibodies; Dermatomyositis; Female; Humans; Interferon-Induced Helicase, IFIH1; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence	2020
Good Response to Tofacitinib in Refractory Amyopathic Dermatomyositis. Actas dermo-sifiliograficas, 2021, Volume: 112, Issue:4 Topics: Dermatomyositis; Humans; Piperidines; Pyrimidines; Pyrroles	2021
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis. Rheumatology (Oxford, England), 2018, 12-01, Volume: 57, Issue:12 Topics: Adult; Aged; Dermatomyositis; Drug Therapy, Combination; Female; Ferritins; Glucocorticoids; Humans; Interferon-Induced Helicase, IFIH1; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Piperidines; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Survival Rate; Treatment Outcome	2018
Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib. Rheumatology (Oxford, England), 2019, 06-01, Volume: 58, Issue:6 Topics: Adult; Aged; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Janus Kinase Inhibitors; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Retreatment; Treatment Outcome	2019
Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-Kinase inhibitor tofacitinib - A report of two cases. Journal of autoimmunity, 2019, Volume: 100 Topics: Calcinosis; Dermatomyositis; Female; Humans; Lung Diseases, Interstitial; MAP Kinase Kinase 4; Middle Aged; Piperidines; Pyrimidines; Pyrroles	2019
Atorvastatin-induced dermatomyositis in a 47-year-old woman with Sjögren's syndrome. Acta cardiologica, 2015, Volume: 70, Issue:3 Topics: Anticholesteremic Agents; Atorvastatin; Dermatomyositis; Female; Heptanoic Acids; Humans; Hyperlipidemias; Middle Aged; Pyrroles; Sjogren's Syndrome	2015
Tofacitinib Citrate for Refractory Cutaneous Dermatomyositis: An Alternative Treatment. JAMA dermatology, 2016, 08-01, Volume: 152, Issue:8 Topics: Administration, Oral; Adult; Dermatomyositis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Sampling Studies; Severity of Illness Index; Treatment Outcome	2016
A case of refractory dermatomyositis responsive to tofacitinib. Seminars in arthritis and rheumatism, 2017, Volume: 46, Issue:4 Topics: Azathioprine; Dermatomyositis; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Middle Aged; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Retreatment; Treatment Failure; Treatment Outcome	2017
[Side effects of the HMG-CoA reductase inhibitors (statins). Lupus erythematosus induced by Atorvastatin therapy]. Przeglad lekarski, 2011, Volume: 68, Issue:8 Topics: Anticholesteremic Agents; Arthralgia; Atorvastatin; Autoantibodies; Collagen Diseases; Creatine Kinase; Dermatomyositis; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Middle Aged; Pyrroles; Transaminases	2011
Statin-induced rhabdomyolysis and dermatomyositis: a rare combination. JAAPA : official journal of the American Academy of Physician Assistants, 2012, Volume: 25, Issue:8 Topics: Atorvastatin; Comorbidity; Dermatomyositis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Rhabdomyolysis	2012
Atorvastatin-induced dermatomyositis. The American journal of medicine, 2001, Jun-01, Volume: 110, Issue:8 Topics: Adult; Antibodies, Antinuclear; Apoptosis; Atorvastatin; Creatine Kinase; Dermatomyositis; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Keratinocytes; Male; Pyrroles	2001